Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
- PMID: 2307730
- DOI: 10.1210/jcem-70-3-766
Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
Abstract
To assess the changes in bone mineral density and osteoblastic activity in patients with hyperthyroidism and to investigate the relationship between those changes, we measured bone mineral density and serum osteocalcin in 109 patients with Graves' disease, comprising 75 untreated patients and 34 patients under treatment, and 200 normal controls. The degree of change in bone mineral density was quantified with Z transformation, in which we used means and SDs of bone mineral densities obtained in the process of age- and sex-matched 1:1 pairing developed by ourselves. Bone mineral density was low in female patients with hyperthyroidism in the spine, femur neck, trochanter, and Ward's triangle, but was not low in male patients. Serum osteocalcin was elevated in patients with untreated Graves' disease and correlated negatively with the Z values of bone mineral densities of the spine, femur neck, and trochanter. In conclusion, indices of osteoblastic activity were elevated in patients with hyperthyroidism, probably secondary to a thyroid hormone-induced increase in bone resorption which resulted in reduced bone mineral density. Quantification of the change in bone mineral density by using the parameters derived in the process of age- and sex-matched pairing seems to be an efficient method for statistical analyses.
Similar articles
-
Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.Thyroid. 1994 Summer;4(2):179-82. doi: 10.1089/thy.1994.4.179. Thyroid. 1994. PMID: 7920000 Clinical Trial.
-
Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.J Clin Endocrinol Metab. 2000 Mar;85(3):1099-106. doi: 10.1210/jcem.85.3.6457. J Clin Endocrinol Metab. 2000. PMID: 10720046 Clinical Trial.
-
Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry.Clin Endocrinol (Oxf). 1993 Mar;38(3):283-6. doi: 10.1111/j.1365-2265.1993.tb01007.x. Clin Endocrinol (Oxf). 1993. PMID: 8096166
-
Corticosteroid-induced bone loss in men.J Clin Endocrinol Metab. 1998 Mar;83(3):801-6. doi: 10.1210/jcem.83.3.4621. J Clin Endocrinol Metab. 1998. PMID: 9506731 Review.
-
Thyroid hormones and bone.J Endocrinol. 1993 Oct;139(1):9-18. doi: 10.1677/joe.0.1390009. J Endocrinol. 1993. PMID: 8254298 Review. No abstract available.
Cited by
-
Metabolic and clinical consequences of hyperthyroidism on bone density.Int J Endocrinol. 2013;2013:638727. doi: 10.1155/2013/638727. Epub 2013 Jul 22. Int J Endocrinol. 2013. PMID: 23970897 Free PMC article.
-
Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men.BMC Endocr Disord. 2011 Aug 6;11:15. doi: 10.1186/1472-6823-11-15. BMC Endocr Disord. 2011. PMID: 21819612 Free PMC article.
-
Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.J Bone Metab. 2015 Aug;22(3):135-41. doi: 10.11005/jbm.2015.22.3.135. Epub 2015 Aug 31. J Bone Metab. 2015. PMID: 26389089 Free PMC article.
-
Wnt Inhibitors and Bone Mineral Density in Patients with Graves' Disease Treated with Antithyroid Drugs: A Preliminary Prospective Study.Metabolites. 2022 Jul 29;12(8):711. doi: 10.3390/metabo12080711. Metabolites. 2022. PMID: 36005583 Free PMC article.
-
The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.PLoS One. 2015 Dec 9;10(12):e0144599. doi: 10.1371/journal.pone.0144599. eCollection 2015. PLoS One. 2015. PMID: 26650844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical